Louis F. Fabre - Concepedia

Author

Louis F. Fabre

Texas Research Institute

Also Known As

L F Fabre, L. F. FABRE, L. F. Fabre, L.F. Fabre, LOUIS F. FABRE, Louis F Fabre, Louis F. Fabre, Louis Fabre, Léa Fabre

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Texas Research Institute HOPE Clinic Texas Medical Center Sheppard and Enoch Pratt Hospital Baylor College of Medicine

About

Louis F. Fabre is an author at Texas Research Institute specializing in medicine, pharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.3K
2	Social Sciences	12	12	1K
3	Engineering	1	1	16
4	Health Sciences	1	1	21
5	Natural Sciences	1	1	20

Louis F. Fabre

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo Louis F. Fabre, F.S. Abuzzahab, Mohamed Amin, Biological Psychiatry Sertraline SafetyPsychiatryPsychotropic MedicationMajor DepressionPsychopharmacology	1995	185
A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients G. C. Dunbar, Jay B. Cohn, Louis F. Fabre, The British Journal of Psychiatry Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	1991	176
Clinical Effects of the 5-HT1A Partial Agonists in Depression Donald S. Robinson, Karl Rickels, John P. Feighner, Journal of Clinical Psychopharmacology Psychoactive DrugPsychiatryMood SymptomMedicineAnxiety Symptoms	1990	171
A Randomized, Placebo-Controlled, Dose-Response Trial of Venlafaxine Hydrochloride in the Treatment of Major Depression Richard L. Rudolph, Louis F. Fabre, John P. Feighner, The Journal of Clinical Psychiatry	1998	134
The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety Louis F. Fabre, David M. McLendon The Journal of Clinical Pharmacology Natural CannabinoidsPsychopharmacologyPharmacotherapyCannabinoid PharmacologySocial Sciences	1981	132
The Effect of Major Depression on Sexual Function in Women Louis F. Fabre, Louis C. Smith The Journal of Sexual Medicine	2011	111
Placebo-Controlled Study of the D<sub>4</sub>/5-HT<sub>2A</sub> Antagonist Fananserin in the Treatment of Schizophrenia Philippe Truffinet, Carol A. Tamminga, Louis F. Fabre, American Journal of Psychiatry	1999	92
ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia Louis F. Fabre, Lisa A. Arvanitis, Joseph Pultz, Clinical Therapeutics PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophrenia	1995	92
A study comparing paroxetine placebo and imipramine in depressed patients John P. Feighner, Jay B. Cohn, Louis F. Fabre, Journal of Affective Disorders Paroxetine PlaceboPsychiatryMood SymptomMedicinePsychotropic Medication	1993	76
Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia Joseph Mendels, Ari Kiev, Louis F. Fabre Depression and Anxiety Depressed OutpatientsPsychiatryMood SymptomPsychotropic MedicationCitalopram Patients	1999	69

Page 1